Basal level of FANCD2 monoubiquitination is required for the maintenance of a sufficient number of licensed-replication origins to fire at a normal rate

Oncotarget

Volumn 5, Issue 5, 2014, Pages 1326-1337

  Panneerselvam, Jayabal ^a   Pickering, Anna ^a   Han, Bing ^a   Li, Liantao ^b   Zheng, Junnian ^b   Zhang, Jun ^c   Zhang, Yanbin ^d   Fei, Peiwen ^a  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^b XUZHOU MEDICAL UNIVERSITY   (China)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

FANCD2; Replication

Indexed keywords

FANCONI ANEMIA GROUP D2 PROTEIN; MINICHROMOSOME MAINTENANCE PROTEIN 3; MINICHROMOSOME MAINTENANCE PROTEIN;

ARTICLE; CELL CYCLE S PHASE; CONTROLLED STUDY; DNA REPLICATION ORIGIN; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; MUTANT; NUCLEOTIDE SEQUENCE; PROTEIN PROTEIN INTERACTION; UBIQUITINATION; DNA REPLICATION; GENETICS; HEK293 CELL LINE; METABOLISM; S PHASE CELL CYCLE CHECKPOINT;

DNA REPLICATION; FANCONI ANEMIA COMPLEMENTATION GROUP D2 PROTEIN; GENOMIC INSTABILITY; HEK293 CELLS; HUMANS; MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 3; MINICHROMOSOME MAINTENANCE PROTEINS; S PHASE CELL CYCLE CHECKPOINTS; UBIQUITINATION;

EID: 84898657165     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.1796     Document Type: Article

References (39)

1. Aparicio OM, Weinstein DM, and Bell SP. Components and dynamics of DNA replication complexes in S. cerevisiae: redistribution of MCM proteins and Cdc45p during S phase. Cell, 1997; 91: 59-69.
2. Nishitani H, Lygerou Z, Nishimoto T, and Nurse P. The Cdt1 protein is required to license DNA for replication in fission yeast. Nature, 2000; 404: 625-628.
3. Zhang Y, Yu Z, Fu X, and Liang C. Noc3p, a bHLH protein, plays an integral role in the initiation of DNA replication in budding yeast. Cell, 2002; 109: 849-860.
4. Sacco E, Hasan MM, Alberghina L, and Vanoni M. Comparative analysis of the molecular mechanisms controlling the initiation of chromosomal DNA replication in yeast and in mammalian cells. Biotechnol Adv, 2012; 30: 73-98.
5. Truong LN and Wu X. Prevention of DNA re-replication in eukaryotic cells. J Mol Cell Biol, 2011; 3: 13-22.
6. Forsburg SL. Eukaryotic MCM proteins: beyond replication initiation. Microbiol Mol Biol Rev, 2004; 68: 109-131.
7. Moyer SE, Lewis PW, and Botchan MR. Isolation of the Cdc45/Mcm2-7/GINS (CMG) complex, a candidate for the eukaryotic DNA replication fork helicase. Proc Natl Acad Sci U S A, 2006; 103: 10236-10241.
8. Bochman ML and Schwacha A. The Mcm2-7 complex has in vitro helicase activity. Mol Cell, 2008; 31: 287-293.
9. Lau E, Tsuji T, Guo L, Lu SH, and Jiang W. The role of prereplicative complex (pre-RC) components in oncogenesis. FASEB J, 2007; 21: 3786-3794.
10. Kawabata T, Luebben SW, Yamaguchi S, Ilves I, Matise I, Buske T, Botchan MR, and Shima N. Stalled fork rescue via dormant replication origins in unchallenged S phase promotes proper chromosome segregation and tumor suppression. Mol Cell, 2011; 41: 543-553.
11. Wang W. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat Rev Genet, 2007; 8: 735-748.
12. Fei P, Yin J, and Wang W. New advances in the DNA damage response network of Fanconi anemia and BRCA proteins. FAAP95 replaces BRCA2 as the true FANCB protein. Cell Cycle, 2005; 4: 80-86.
13. Kim H and D'Andrea AD. Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway. Genes Dev, 2012; 26: 1393-1408.
14. Pickering A, Zhang J, Panneerselvam J, and Fei P. Advances in the understanding of Fanconi anemia tumor suppressor pathway. Cancer Biol Ther, 2013; 14:
15. Park HK, Wang H, Zhang J, Datta S, and Fei P. Convergence of Rad6/Rad18 and Fanconi anemia tumor suppressor pathways upon DNA damage. PLoS One, 2010; 5: e13313.
16. Zhang J, Zhao D, Wang H, Lin CJ, and Fei P. FANCD2 monoubiquitination provides a link between the HHR6 and FA-BRCA pathways. Cell Cycle, 2008; 7: 407-413.
17. Schlacher K, Wu H, and Jasin M. A distinct replication fork protection pathway connects Fanconi anemia tumor suppressors to RAD51-BRCA1/2. Cancer Cell, 2012; 22: 106-116.
18. Fu D, Dudimah FD, Zhang J, Pickering A, Paneerselvam J, Palrasu M, Wang H, and Fei P. Recruitment of DNA polymerase eta by FANCD2 in the early response to DNA damage. Cell Cycle, 2013; 12: 803-809.
19. Pickering A, Panneerselvam J, Zhang J, Zheng J, Zhang Y, and Fei P. In vitro FANCD2 monoubiquitination by HHR6 and hRad18. Cell Cycle, 2013; 12:
20. Swift M. Fanconi's anaemia in the genetics of neoplasia. Nature, 1971; 230: 370-373.
21. Zhang J, Zhao D, Park HK, Wang H, Dyer RB, Liu W, Klee GG, McNiven MA, Tindall DJ, Molina JR, and Fei P. FAVL elevation in human tumors disrupts Fanconi anemia pathway signaling and promotes genomic instability and tumor growth. J Clin Invest, 2010;120:1524-1534
22. Panneerselvam J, Park HK, Zhang J, Dudimah FD, Zhang P, Wang H, and Fei P. FAVL impairment of the Fanconi anemia pathway promotes the development of human bladder cancer. Cell Cycle, 2012; 11: 2947-2955.
23. D'Andrea AD. Susceptibility pathways in Fanconi's anemia and breast cancer. N Engl J Med, 2010; 362: 1909-1919.
24. Huo L, Wu R, Yu Z, Zhai Y, Yang X, Chan TC, Yeung JT, Kan J, and Liang C. The Rix1 (Ipi1p-2p-3p) complex is a critical determinant of DNA replication licensing independent of their roles in ribosome biogenesis. Cell Cycle, 2012; 11: 1325-1339.
25. Ramanathan HN and Ye Y. Revoking the cellular license to replicate: yet another AAA assignment. Mol Cell, 2011; 44: 3-4.
26. Bell SP and Dutta A. DNA replication in eukaryotic cells. Annu Rev Biochem, 2002; 71: 333-374.
27. Stillman B. Cell cycle control of DNA replication. Science, 1996; 274: 1659-1664.
28. Montes de Oca R, Andreassen PR, Margossian SP, Gregory RC, Taniguchi T, Wang X, Houghtaling S, Grompe M, and D'Andrea AD. Regulated interaction of the Fanconi anemia protein, FANCD2, with chromatin. Blood, 2005; 105: 1003-1009.
29. Schepers A and Papior P. Why are we where we are?. Understanding replication origins and initiation sites in eukaryotes using ChIP-approaches. Chromosome Res, 2010; 18: 63-77.
30. Todorovic V, Giadrossi S, Pelizon C, Mendoza-Maldonado R, Masai H, and Giacca M. Human origins of DNA replication selected from a library of nascent DNA. Mol Cell, 2005; 19: 567-575.
31. Thangavel S, Mendoza-Maldonado R, Tissino E, Sidorova JM, Yin J, Wang W, Monnat RJ. Jr., Falaschi A, and Vindigni A, Human RECQ1 and RECQ4 helicases play distinct roles in DNA replication initiation. Mol Cell Biol, 2010; 30: 1382-1396.
32. Gurudatta BV, Yang J, Van Bortle K, Donlin-Asp PG, and Corces VG. Dynamic changes in the genomic localization of DNA replication-related element binding factor during the cell cycle. Cell Cycle, 2013; 12: 1605-1615.
33. Smogorzewska A, Matsuoka S, Vinciguerra P, McDonald ER, 3rd, Hurov KE, Luo J, Ballif BA, Gygi SP, Hofmann K, D'Andrea AD, and Elledge SJ. Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair. Cell, 2007; 129: 289-301.
34. Bochman ML and Schwacha A. The Mcm complex: unwinding the mechanism of a replicative helicase. Microbiol Mol Biol Rev, 2009; 73: 652-683.
35. Fei P, Wang W, Kim SH, Wang S, Burns TF, Sax JK, Buzzai M, Dicker DT, McKenna WG, Bernhard EJ, and El-Deiry WS. Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growth. Cancer Cell, 2004; 6: 597-609.
36. Panneerselvam J, Pickering A, Zhang J, Wang H, Tian H, Zheng J, and Fei P. A Hidden Role of the Inactivated FANCD2: Upregulating DeltaNp63. Oncotarget, 2013;
37. Sugiyama T, Chino M, Tsurimoto T, Nozaki N, and Ishimi Y. Interaction of heliquinomycin with single-stranded DNA inhibits MCM4/6/7 helicase. J Biochem, 2012; 151: 129-137.
38. Meetei AR, de Winter JP, Medhurst AL, Wallisch M, Waisfisz Q, van de Vrugt HJ, Oostra AB, Yan Z, Ling C, Bishop CE, Hoatlin ME, Joenje H, and Wang W. A novel ubiquitin ligase is deficient in Fanconi anemia. Nat Genet, 2003; 35: 165-170.
39. Stewart SA, Dykxhoorn DM, Palliser D, Mizuno H, Yu EY, An DS, Sabatini DM, Chen IS, Hahn WC, Sharp PA, Weinberg RA, and Novina CD. Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA, 2003; 9: 493-501.